Ketamine and cancer pain: The reports of my death have been greatly exaggerated

Journal of Clinical Oncology

Volumn 31, Issue 10, 2013, Pages 1373-1374

  Jackson, Kate ^a   Franco, Michael ^a   William, Leeroy ^a,b   Poon, Peter ^a,c   Pisasale, Maria ^d,e   Kenner, David ^b   Brumley, David ^f   Mewett, Greg ^f   Ashby, Michael ^g   Viney, Melissa ^e,h   Kerr, David ^d,i  

^a MONASH UNIVERSITY   (Australia)

^b EASTERN HEALTH   (Australia)

^c Eastern Palliative Care   (Australia)

^d Werribee Mercy Health   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f Grampians Regional Palliative Care   (Australia)

^g ROYAL HOBART HOSPITAL   (Australia)

^h GEELONG HOSPITAL   (Australia)

ⁱ AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; HALOPERIDOL; KETAMINE; MIDAZOLAM; OPIATE;

ANALGESIC ACTIVITY; CANCER PAIN; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; LETTER; LOW DRUG DOSE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

FEMALE; HUMANS; KETAMINE; MALE; NEOPLASMS; PAIN, INTRACTABLE;

EID: 84876080121     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.1235     Document Type: Letter

References (7)

1. Hardy J, Quinn S, Fazekas B, et al: Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol 30:3611-3617, 2012
2. Jackson K, Ashby M, Martin P, et al: "Burst" ketamine for refractory cancer pain: An open-label audit of 39 patients. J Pain Symptom Manage 22:834-842, 2001 (Pubitemid 32884376)
3. Jackson K, Ashby M, Howell D, et al: The effectiveness and adverse effects profile of "burst" ketamine in refractory cancer pain: The VCOG PM 1-00 study. J Palliat Care 26:176-183, 2010
4. Loix S, De Kock M, Henin P: The anti-inflammatory effects of ketamine: State of the art. Acta Anaesthesiol Belg 62:47-58, 2011
5. Quibell R, Prommer EE, Mihalyo M, et al: Ketamine*. J Pain Symptom Manage 41:640-649, 2011
6. Woolf CJ, Bennett GJ, Doherty M, et al: Towards a mechanism-based classification of pain? Pain 77:227-229, 1998 (Pubitemid 28451510)
7. National Cancer Institute Cancer Therapy Evaluation Program: Common Toxicity Criteria, v. 2.0. Bethesda, MD, National Cancer Institute, 1999